Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Pfizer closes acquisition of Hospira for $15bn New York-based Pfizer has closed the acquisition of Lake Forest-based manufacturer of injectable drugs and infusion devices Hospira for around $15bn. Production & Manufacturing > Manufacturing > News
Clinical Phase I dosing of Glenmark Pharmaceuticals’ GNR 830 completed in Netherlands By PBR Staff Writer
Glenmark Pharmaceuticals, a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, has completed the clinical Phase 1 dosing of its GBR 830, a monoclonal antibody, in the Netherlands.
Contract Research & Services > Clinical Trials > News AstraZeneca secures US FDA approval for Brilinta for long term use By PBR Staff Writer
The US Food and Drug Administration (FDA) has given its approval to AstraZeneca for the new 60mg dose of its blood thinner Brilinta (ticagrelor) tablets, which can used by patients with a history of heart attack or acute coronary syndrome (ACS).
Regulatory Affairs > News Cellectis teams up with MD Anderson Cancer Center for cancer immnotherapy By PBR Staff Writer
Cellectis, a gene editing company that uses proprietary technologies to develop CAR T-cell products in adoptive immunotherapy for cancer, and The University of Texas MD Anderson Cancer Center have formed a research and development partnership to bring new cellular immunotherapies to patients suffering from different kinds of liquid tumors.
Automation > IT & Software > News
Novo Nordisk invests $74m in Denmark warehouse By PBR Staff Writer
Novo Nordisk is investing DKK500m ($74m) in a new a warehouse in Hillerød, Denmark.
Production & Manufacturing > Manufacturing > News Pfizer closes acquisition of Hospira for $15bn By PBR Staff Writer
New York-based Pfizer has closed the acquisition of Lake Forest-based manufacturer of injectable drugs and infusion devices Hospira for around $15bn.
Production & Manufacturing > Manufacturing > News Daiichi Sankyo signs deal to market AstraZeneca's FluMist in Japan By PBR Staff Writer
AstraZeneca has granted Daiichi Sankyo an exclusive license to market its FluMist Quadrivalent in Japan.
Contract Research & Services > Contract Services > News

Latest News and Insight by Sector

Production & Manufacturing

Novo Nordisk invests $74m in Denmark warehouse
By PBR Staff Writer
Novo Nordisk is investing DKK500m ($74m) in a new a warehouse in Hillerød, Denmark.
Production & Manufacturing > Manufacturing > News
Pfizer closes acquisition of Hospira for $15bn
By PBR Staff Writer
New York-based Pfizer has closed the acquisition of Lake Forest-based manufacturer of injectable drugs and infusion devices Hospira for around $15bn.
Production & Manufacturing > Manufacturing > News

Drug Research

US FDA approves Tesaro's chemotherapy anti-nausea drug
By PBR Staff Writer
The US Food and Drug Administration has approved Tesaro's chemotherapy anti-nausea drug, Varubi (rolapitant).
Drug Research > Drug Delivery > News
Dicerna submits IND application for DCR-PH1 therapeutic candidate
By PBR Staff Writer
Dicerna Pharmaceuticals has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) for its DCR-PH1 therapeutic candidate.
Drug Research > Drug Delivery > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Clinical Phase I dosing of Glenmark Pharmaceuticals’ GNR 830 completed in Netherlands
By PBR Staff Writer
Glenmark Pharmaceuticals, a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, has completed the clinical Phase 1 dosing of its GBR 830, a monoclonal antibody, in the Netherlands.
Contract Research & Services > Clinical Trials > News
Daiichi Sankyo signs deal to market AstraZeneca's FluMist in Japan
By PBR Staff Writer
AstraZeneca has granted Daiichi Sankyo an exclusive license to market its FluMist Quadrivalent in Japan.
Contract Research & Services > Contract Services > News

Automation

Cellectis teams up with MD Anderson Cancer Center for cancer immnotherapy
By PBR Staff Writer
Cellectis, a gene editing company that uses proprietary technologies to develop CAR T-cell products in adoptive immunotherapy for cancer, and The University of Texas MD Anderson Cancer Center have formed a research and development partnership to bring new cellular immunotherapies to patients suffering from different kinds of liquid tumors.
Automation > IT & Software > News
RedHill Biopharma gets notice of allowance for new Israeli patent covering RHB-104 to treat Crohn's disease
RedHill Biopharma has received a Notice of Allowance from the Israeli Patent Office (ILPO) for a new Israeli patent No. 207420 covering the formulation of RHB-104, a proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule formulation, with potent intracellular, anti-mycobacterial and anti-inflammatory properties.
Automation > IT & Software > News

Regulatory Affairs

AstraZeneca secures US FDA approval for Brilinta for long term use
By PBR Staff Writer
The US Food and Drug Administration (FDA) has given its approval to AstraZeneca for the new 60mg dose of its blood thinner Brilinta (ticagrelor) tablets, which can used by patients with a history of heart attack or acute coronary syndrome (ACS).
Regulatory Affairs > News
European Commission approves Novartis' Revolade for severe aplastic anemia
By PBR Staff Writer
The European Commission approved the use of Novartis' Revolade (eltrombopag) to treat patients with severe aplastic anemia (SAA) who have not responded to other treatments.
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery